drugset
drugset / Trial / NCT01624207

The Efficacy and Safety of Atorva® 20mg Versus Lipitor® 20mg

NCT01624207 ↗

Phase 4 Completed 376 enrolled Seoul National University Hospital Yuhan corp., Seoul, Korea · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The generic formulation of atorvastatin (Atorva®) 20mg was not inferior to the branded formulation of atorvastatin (Lipitor®) 20mg in this 8-week treatment of hyperlipidemic Korean patients. In PP analysis, the LDL cholesterol goal achievement rate was significantly higher in Atorva group. Both treatments were well tolerated.

Timeline

Start
2010-03
Primary completion
2011-01
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 20 mg —

Indications

hyperlipidemia